CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- 8-K Event Material agreement · Executive or director change · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 4 Open-market sale EVP, GM Gene Therapy sold 27,894 shares at $3.12 ($87,029)
- 4 Open-market sale SVP, Treasurer & CAO sold 18,020 shares at $3.09 ($55,682)
- 4 Open-market sale General Counsel and Secretary sold 26,500 shares at $3.12 ($82,680)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale EVP, GM Cell Therapy sold 21,620 shares at $2.72 ($58,806)
- 4 Open-market sale President and CEO sold 105,693 shares at $2.71 ($286,428)
- 8-K Event Delisting notice
- 8-K Event Delisting notice · Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Other events
- DFAN14A Other Proxy Soliciting Materials
- DEFA14A Proxy Proxy Materials
- 8-K Event Executive or director change
- DFAN14A Other Proxy Soliciting Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DFAN14A Other Proxy Soliciting Materials
- 8-K Event Executive or director change
- DEFA14A Proxy Proxy Materials
Page 16 of 65 · 1,296 filings